Lessons from Kawasaki Disease: All Brands of IVIG are not Equal

This publication has 13 references indexed in Scilit:

• Clinical Responses of Patients with Kawasaki Disease to Different Brands of Intravenous Immunoglobulin
  The Journal of Pediatrics, 2006
• Venous and arterial thrombosis following administration of intravenous immunoglobulins
  Blood Coagulation & Fibrinolysis, 2005
• Use of i.v. immune globulin and occurrence of associated acute renal failure and thrombosis
  American Journal of Health-System Pharmacy, 2005
• Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
  Pediatrics, 2004
• Comparative safety and efficacy of two immune globulin products in Kawasaki disease
  The Journal of Pediatrics, 1995
• Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk Factors
  Annals of Internal Medicine, 1994
• Immunoglobulin preparations for intravenous administration
  Allergy, 1994
• Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]
  Journal of Clinical Investigation, 1993
• Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood
  The Journal of Pediatrics, 1992
• Effect of Various Treatments of Gamma‐Globulin (IgG) for Achieving Intravenous Tolerance on the Capacity to Interact with Human Monocyte Fc Receptors: A Comparative Study
  Vox Sanguinis, 1986